IT201800009132A1 - LASER DEVICE FOR IMMUNOPROPHYLAXIS - Google Patents
LASER DEVICE FOR IMMUNOPROPHYLAXIS Download PDFInfo
- Publication number
- IT201800009132A1 IT201800009132A1 IT102018000009132A IT201800009132A IT201800009132A1 IT 201800009132 A1 IT201800009132 A1 IT 201800009132A1 IT 102018000009132 A IT102018000009132 A IT 102018000009132A IT 201800009132 A IT201800009132 A IT 201800009132A IT 201800009132 A1 IT201800009132 A1 IT 201800009132A1
- Authority
- IT
- Italy
- Prior art keywords
- laser
- rays
- buffer
- pad
- immunoprophylaxis
- Prior art date
Links
- 244000052769 pathogen Species 0.000 claims description 26
- 230000001717 pathogenic effect Effects 0.000 claims description 16
- 210000003491 skin Anatomy 0.000 claims description 6
- 210000003462 vein Anatomy 0.000 claims description 6
- 210000004207 dermis Anatomy 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000012780 transparent material Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 238000002255 vaccination Methods 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000013307 optical fiber Substances 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- 241000700605 Viruses Species 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 239000003948 anatoxin Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006054 immunological memory Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0624—Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/063—Radiation therapy using light comprising light transmitting means, e.g. optical fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
-λο3ο\ 3⁄4ocoo 32A -λο3ο \ 3⁄4ocoo 32A
Brevetto per Invenzione Industriale dal titolo “DISPOSITIVO LASER PER IMMUNOPROFILASSI”. Patent for Industrial Invention entitled "LASER DEVICE FOR IMMUNOPROPHYLASSIS".
Titolare ed inventore: Signor LAGHI Germano, di nazionalità italiana, residente a 48018 Faenza (Ravenna) in via Reda 160. Owner and inventor: Mr. LAGHI Germano, of Italian nationality, residing in 48018 Faenza (Ravenna) in via Reda 160.
DESCRIZIONE DESCRIPTION
Campo dell'invenzione. Field of the invention.
L’invenzione è relativa ad un dispositivo per immunoprofilassi in grado di generare un’ immunità acquisita e generando anticorpi specifici in un organismo senza dover iniettare o far ingerire patogeni. Per patogeni si intendono elementi infettanti vivo o morti oppure patogeni derivati, come ad esempio anatossine, antigeni, proteine, acidi nucleici contenenti virus, virus causanti patologie degenerative, batteri, parassiti e similari. Il dispositivo consente, inoltre, vaccinazioni multiple in contemporanea senza effetti collaterali. The invention relates to an immunoprophylaxis device capable of generating acquired immunity and generating specific antibodies in an organism without having to inject or ingest pathogens. By pathogens we mean live or dead infectious elements or derived pathogens, such as for example anatoxins, antigens, proteins, nucleic acids containing viruses, viruses causing degenerative diseases, bacteria, parasites and the like. The device also allows multiple vaccinations at the same time without side effects.
Stato della tecnica. State of the art.
Attualmente le vaccinazioni sono effettuate tramite iniezioni o per ingestione di pillole con agenti patogeni. Queste modalità di vaccinazione presentano, però, diversi svantaggi. Nell’introduzione nell’organismo vengono usati diversi eccipienti, in alcuni casi dannosi per la salute. Si possono verificare casi di intolleranze al vaccino e/o reazioni allergiche. L’introduzione di patogeni nell’organismo può, inoltre, portare a reazioni soggettive in base a diversi fattori, come ad esempio stato di salute della persona a cui viene iniettato il vaccino, concomitanza di alcune patologie ed età. Altro svantaggio delle tecniche attuali è dato dal fatto di dover realizzare singole dosi di vaccino. Questo comporta costi per ogni confezione prodotta. Currently vaccinations are carried out via injections or by ingestion of pills with pathogens. However, these vaccination methods have several disadvantages. Various excipients are used in the introduction into the body, in some cases harmful to health. There may be cases of vaccine intolerances and / or allergic reactions. The introduction of pathogens into the body can also lead to subjective reactions based on various factors, such as the state of health of the person to whom the vaccine is injected, concomitance of certain diseases and age. Another disadvantage of current techniques is the fact that single doses of the vaccine have to be made. This involves costs for each package produced.
Sommario dell'invenzione. Summary of the invention.
Oggetto dell’invenzione è un dispositivo in grado di evitare gli svantaggi menzionati con una sorgente di fotoni generata da un laser ed indirizzata ad un tampone in cui sono presenti i patogeni e dove i raggi, che hanno attraversato il tampone, sono indirizzati ad un organismo. In altra forma di realizzazione detti raggi, in uscita dal tampone, sono raccolti da un convogliatore fotonico in fibra ottica rivestita e portati in un punto sul derma di un organismo in prossimità di una vena. Il dispositivo utilizza un flusso fotonico a bassa frequenza a flusso continuo oppure a flusso pulsato. Il trovato è in grado di sostituire i metodi tradizionali di vaccinazione evitando l’introduzione di agenti patogeni nell’organismo. La trasmissione di fotoni che hanno attraversato il contenitore con gli elementi patogeni porta neH’organismo la percezione della presenza di tali agenti patogeni scatenando la reazione immunitaria come se fossero stati introdotti i patogeni nel corpo. La luce coerente del laser, attraversando il contenitore con gli elementi patogeni, modifica la propria struttura in base agli elementi patogeni presenti nel contenitore, simulando la presenza del patogeno neH’organismo con i fotoni che, modificati nell’attraversamento del contenitore in cui sono presenti i patogeni, variano in funzione di quanto presente nel tampone. Questo consente di trasferire questa interazione in grado di generare anticorpi specifici direttamente ad un organismo, ad un altro tampone o ad una banca dati in grado di conservare le frequenze modificate e catalogate in funzione del patogeno, in tal modo si può acquisire una memoria immunologica da utilizzare per vaccinazioni sia singole che multiple. Questi ed altri scopi e vantaggi del presente risultamento saranno maggiormente evidenti dalla seguente descrizione dettagliata di una forma di realizzazione preferita ma non esclusiva, con riferimento ai disegni allegati in cui il trovato è illustrato in via puramente indicativa ed in quanto tale, non limitativa. The object of the invention is a device capable of avoiding the aforementioned disadvantages with a photon source generated by a laser and addressed to a pad in which the pathogens are present and where the rays, which have passed through the pad, are directed to an organism. . In another embodiment, said rays, exiting the pad, are collected by a coated optical fiber photonic conveyor and brought to a point on the dermis of an organism near a vein. The device uses a continuous flow or pulsed flow low frequency photonic flux. The invention is able to replace traditional vaccination methods avoiding the introduction of pathogens into the body. The transmission of photons that have passed through the container with the pathogenic elements leads the body to perceive the presence of these pathogens, triggering the immune reaction as if the pathogens had been introduced into the body. The coherent light of the laser, passing through the container with the pathogenic elements, modifies its structure according to the pathogenic elements present in the container, simulating the presence of the pathogen in the organism with the photons which, modified when crossing the container in which they are present. the pathogens vary according to what is present in the swab. This allows to transfer this interaction capable of generating specific antibodies directly to an organism, to another buffer or to a database capable of storing the frequencies modified and cataloged according to the pathogen, in this way it is possible to acquire an immunological memory from use for both single and multiple vaccinations. These and other objects and advantages of the present result will be more evident from the following detailed description of a preferred but not exclusive embodiment, with reference to the attached drawings in which the invention is illustrated purely by way of indication and as such, not limiting.
Breve descrizione dei disegni. Brief description of the drawings.
La figura 1 è vista di uno schema di un laser con flusso fotonico inviato su tampone, alla cui uscita è presente la pelle di un organismo. La figura 2 è vista di uno schema comprendente gli stessi elementi presenti nella figura 1 ma con un convogliatore di fotoni in fibra ottica in grado di focalizzare i raggi del laser in un punto preciso sul derma in corrispondenza di una vena. La figura 3 è vista di uno schema di un laser, di un tampone e di un apparato di raccolta dati. La figura 4 è vista di ulteriore schema di trasmissione dati, catalogati in base al patogeno, da un computer ad un laser, per poi essere trasmessi con i raggi del laser alla pelle di un organismo. Figure 1 is a view of a diagram of a laser with photonic flow sent on a swab, at the exit of which there is the skin of an organism. Figure 2 is a view of a diagram comprising the same elements present in Figure 1 but with an optical fiber photon conveyor capable of focusing the laser rays in a precise point on the dermis in correspondence with a vein. Figure 3 is a schematic view of a laser, swab, and data collection apparatus. Figure 4 is a view of a further data transmission scheme, cataloged according to the pathogen, from a computer to a laser, to then be transmitted with the laser beams to the skin of an organism.
Descrizione dettagliata. Detailed description.
Il dispositivo laser per l'immunoprofilassi è costituito da un laser 1 a bassa potenza che emette fotoni di luce armonica, da un tampone 2 comprendente un contenitore chiuso di materiale trasparente e privo di distorsione fotonica, come ad esempio cristallo, poiché privo di effetti torsionali sui fotoni, contenente in forma liquida, gelatinosa o solida un campione di almeno un patogeno con conservanti, acqua o solventi a seconda del patogeno da irraggiare con il laser 1 , dove i raggi del laser 1 in uscita dal tampone 2 vengono^ indirizzati sulla pelle. Nel tampone 2 non devono essere presenti tracce di cromosomi oltre a quelle dei patogeni. In altra forma di realizzazione il dispositivo laser per immunoprofilassi è costituito da un laser 1 a bassa potenza, da un tampone 2 e da un convogliatore 3 dei raggi emessi dal laser 1 dopo che hanno attraversato il tampone 2 per concentrare i raggi in un punto preciso del derma in prossimità di una vena. Il convogliatore 3 è costituito, ad esempio, da fibra ottica rivestita, dove il segnale viene trasferito all’organismo conservando la linearità del flusso fotonico. In ulteriore altra forma di realizzazione il dispositivo laser per immunoprofilassi è costituito da laser 1 a bassa potenza, da un tampone 2 e da un apparato 4 composto da un rilevatore 5 dei raggi in uscita dal tampone 2 e da un computer 6, dove i raggi in uscita dal tampone 2 vengono catalogati in funzione dei patogeni presenti nel tampone 2 e memorizzati. Il rilevatore 5 è, ad esempio, un rilevatore ottico in grado di rilevare la frequenza elettromagnetica dei raggi in uscita dal tampone. In questo caso i dati raccolti vengono poi trasmessi dal computer 6 al laser 1 per replicare, nell’emissione di fotoni, lo stesso flusso di fotoni in uscita da un tampone 2 specifico per un determinato patogeno, con il laser 1 incidente sulla pelle di un organismo in prossimità di una vena. La luce laser utilizzata è del tipo medicale, a bassa energia e con lunghezza d’onda e potenza non dannosa per le cellule ed adatto alla scansione di parametri biologici. Il laser 1, utilizzato per simulare la presenza patogena e generare anticorpi specifici a scopo di immunoprofilassi, è un laser a bassa potenza con lunghezza d’onda compresa fra i 600 (seicento) ed i 900 (novecento) nm (rosso ed infrarosso), con potenze variabili da bassissime, ovvero di classe 1, a potenze superiori, classi 3A e 3B. La luce armonica strutturata emessa viene modificata in base al patogeno che attraversa. La trasmissione di questi parametri induce nelPorganismo la simulazione e la percezione del patogeno, senza però essere presente nel flusso venoso e senza gli effetti dannosi che si possono verificare all’interno dell’organismo in cui è avvenuta l’iniezione del patogeno o l’assunzione orale di tali patogeni. Il trovato è suscettibile di numerose modifiche e varianti tutte rientranti nell’ambito del concetto inventivo. Tutti i dettagli possono essere sostituiti da altri tecnicamente equivalenti senza per questo uscire dal campo di protezione sancito dalle rivendicazioni. The laser device for immunoprophylaxis consists of a low-power laser 1 that emits photons of harmonic light, a buffer 2 comprising a closed container of transparent material and free of photonic distortion, such as for example crystal, since it is free of torsional effects on photons, containing in liquid, gelatinous or solid form a sample of at least one pathogen with preservatives, water or solvents depending on the pathogen to be irradiated with the laser 1, where the rays of the laser 1 exiting from the pad 2 are ^ directed onto the skin . Buffer 2 must not contain traces of chromosomes other than those of the pathogens. In another embodiment, the laser device for immunoprophylaxis consists of a low-power laser 1, a pad 2 and a conveyor 3 of the rays emitted by the laser 1 after they have passed through the pad 2 to concentrate the rays in a precise point of the dermis near a vein. The conveyor 3 consists, for example, of coated optical fiber, where the signal is transferred to the body while maintaining the linearity of the photonic flow. In a further embodiment, the laser device for immunoprophylaxis consists of a low-power laser 1, a buffer 2 and an apparatus 4 composed of a detector 5 of the rays coming out of the buffer 2 and a computer 6, where the rays at the exit from buffer 2 they are cataloged according to the pathogens present in buffer 2 and stored. The detector 5 is, for example, an optical detector capable of detecting the electromagnetic frequency of the rays exiting the pad. In this case the collected data are then transmitted from the computer 6 to the laser 1 to replicate, in the photon emission, the same flow of photons coming out of a buffer 2 specific for a specific pathogen, with the laser 1 incident on the skin of a organism near a vein. The laser light used is of the medical type, low energy and with a wavelength and power not harmful to cells and suitable for scanning biological parameters. Laser 1, used to simulate the pathogenic presence and generate specific antibodies for the purpose of immunoprophylaxis, is a low power laser with a wavelength between 600 (six hundred) and 900 (nine hundred) nm (red and infrared), with powers ranging from very low, i.e. class 1, to higher powers, classes 3A and 3B. The structured harmonic light emitted is modified according to the pathogen it passes through. The transmission of these parameters induces in the organism the simulation and perception of the pathogen, without however being present in the venous flow and without the harmful effects that can occur inside the organism in which the pathogen has been injected or taken. oral disease of such pathogens. The invention is susceptible of numerous modifications and variations, all of which are within the scope of the inventive concept. All the details can be replaced by other technically equivalent ones without thereby departing from the field of protection sanctioned by the claims.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102018000009132A IT201800009132A1 (en) | 2018-10-03 | 2018-10-03 | LASER DEVICE FOR IMMUNOPROPHYLAXIS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102018000009132A IT201800009132A1 (en) | 2018-10-03 | 2018-10-03 | LASER DEVICE FOR IMMUNOPROPHYLAXIS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IT201800009132A1 true IT201800009132A1 (en) | 2020-04-03 |
Family
ID=65010821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT102018000009132A IT201800009132A1 (en) | 2018-10-03 | 2018-10-03 | LASER DEVICE FOR IMMUNOPROPHYLAXIS |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT201800009132A1 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4402318A (en) * | 1975-11-28 | 1983-09-06 | Swartz Mitchell R | Method for inactivating viruses, bacteria, etc. in vitro and production of vaccines |
| US20100282980A1 (en) * | 2009-05-11 | 2010-11-11 | Caridianbct Biotechnologies, Llc | Stable Calibration Means for Apparatus for Photo Reduction of Contaminants in Blood |
| US20120310309A1 (en) * | 2011-06-01 | 2012-12-06 | Erchonia Corporation | Adjustable Polarity Laser Device and Polarized Low-Level Laser Therapy Method |
| US20150072337A1 (en) * | 2012-01-17 | 2015-03-12 | William Marsh Rice University | Theranostic methods and systems for diagnosis and treatment of malaria |
-
2018
- 2018-10-03 IT IT102018000009132A patent/IT201800009132A1/en unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4402318A (en) * | 1975-11-28 | 1983-09-06 | Swartz Mitchell R | Method for inactivating viruses, bacteria, etc. in vitro and production of vaccines |
| US20100282980A1 (en) * | 2009-05-11 | 2010-11-11 | Caridianbct Biotechnologies, Llc | Stable Calibration Means for Apparatus for Photo Reduction of Contaminants in Blood |
| US20120310309A1 (en) * | 2011-06-01 | 2012-12-06 | Erchonia Corporation | Adjustable Polarity Laser Device and Polarized Low-Level Laser Therapy Method |
| US20150072337A1 (en) * | 2012-01-17 | 2015-03-12 | William Marsh Rice University | Theranostic methods and systems for diagnosis and treatment of malaria |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Saini et al. | Prospects in the application of photodynamic therapy in oral cancer and premalignant lesions | |
| Maeding et al. | Boosting tumor-specific immunity using PDT | |
| Leinweber et al. | Two-photon calcium imaging in mice navigating a virtual reality environment | |
| US20170340895A1 (en) | Electromagnetic radiation targeting devices, assemblies, systems and methods | |
| De Santis et al. | Mechanical and thermal properties of dental composites cured with CAD/CAM assisted solid-state laser | |
| Subochev et al. | Simultaneous in vivo imaging of diffuse optical reflectance, optoacoustic pressure, and ultrasonic scattering | |
| Semyachkina-Glushkovskaya et al. | Brain waste removal system and sleep: Photobiomodulation as an innovative strategy for night therapy of brain diseases | |
| IT201800009132A1 (en) | LASER DEVICE FOR IMMUNOPROPHYLAXIS | |
| Kalyanov et al. | Time domain near-infrared optical tomography with time-of-flight spad camera: The new generation | |
| Rostami et al. | The Evaluation of SWEEPS Plus Antimicrobial Photodynamic Therapy with Indocyanine Green in Eliminating Enterococcus faecalis Biofilm from Infected Root Canals: An In Vitro Study | |
| CN104083150A (en) | Method for diagnosing early cancer with color CCD camera shooting technology | |
| CN203263363U (en) | Portable venepuncture projector | |
| KR20130094127A (en) | Laser device for mouth | |
| KR102069603B1 (en) | System and method for producing localized photo-thrombosis animal model | |
| Kunstek et al. | Aspects of antiviral strategies based on different phototherapy approaches: Hit by the light | |
| JP2012154920A5 (en) | ||
| Logan et al. | Multispectral near-infrared imaging of composite restorations in extracted teeth | |
| Long et al. | Dental optical tomography with upconversion nanoparticles—a feasibility study | |
| RU111766U1 (en) | SEALED LED CURRENT (OPTIONS) | |
| Nakamura et al. | Physico-Mechanical Properties of a Newly Developed Base Material Containing Mineral Trioxide Aggregate | |
| Shahi Ardakani et al. | In Vitro Assessment of SWEEPS and Antimicrobial Photodynamic Therapy Alone or in Combination for Eradicating Enterococcus faecalis Biofilm in Root Canals | |
| CN204033314U (en) | Automatic tracking system | |
| Bui | Effect of schistosome egg antigens on a Listeria vector HIV-1 vaccine | |
| Prevenslik | Mystery pulmonary and neurological symptoms by EM radiation from the Coronavirus | |
| Sarangi et al. | Monitoring Molecular Aging of Lens Proteins using Noninvasive Quasi-Elastic Light Scattering |